WallStreetZenWallStreetZen

NASDAQ: NMRA
Neumora Therapeutics Inc Stock Ownership - Who owns Neumora Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neumora Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daljit Singh AuroraChief Strategy Officer2025-02-188,565$1.68
$14.35kSell
Paul L. BernsTitle Chief Executive Officer and Chairman of the Board2025-02-1813,871$1.69
$23.47kSell
Robert A. LenzHead of RD2025-02-185,614$1.67
$9.38kSell
Michael Lee MilliganTitle Chief Financial Officer Principal Accounting Officer2025-02-181,978$1.69
$3.35kSell
Joshua PintoPresident2025-02-188,048$1.68
$13.48kSell
Matthew K. FustDirector2024-10-186,205$8.79
$54.54kBuy
Matthew K. FustDirector2024-10-1814,049$17.04
$239.32kSell
Matthew K. FustDirector2024-10-187,844$2.52
$19.77kBuy
Matthew K. FustDirector2024-10-173,783$8.32
$31.47kBuy
Matthew K. FustDirector2024-10-177,739$17.01
$131.64kSell

1 of 3

NMRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NMRA insiders and whales buy or sell their stock.

NMRA Shareholders

What type of owners hold Neumora Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kristina Burow29.32%47,490,756$30.73MInsider
Amgen Inc21.84%35,368,653$22.88MInsider
Arch Venture Partners XII LLC19.71%31,932,138$20.66MInsider
Arch Venture Partners X LLC19.71%31,932,138$20.66MInsider
Fmr LLC4.84%7,838,577$5.07MInstitution
Paul L. Berns4.65%7,538,101$4.88MInsider
Blackrock Inc4.39%7,106,996$4.60MInstitution
Softbank Group Corp4.04%6,541,190$4.23MInstitution
T Rowe Price Investment Management Inc3.09%5,002,799$3.24MInstitution
Vanguard Group Inc2.82%4,572,308$2.96MInstitution

1 of 3

NMRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NMRA33.69%66.31%Net SellingNet Selling
LXEO80.55%19.45%Net SellingNet Buying
OBIO42.93%57.07%Net SellingNet Selling
TIL6.44%93.56%
CSBR1.94%98.06%Net Buying
View Top Biotech Stocks

Neumora Therapeutics Stock Ownership FAQ

Who owns Neumora Therapeutics?

Neumora Therapeutics (NASDAQ: NMRA) is owned by 49.59% institutional shareholders, 97.62% Neumora Therapeutics insiders, and 0.00% retail investors. Kristina Burow is the largest individual Neumora Therapeutics shareholder, owning 47.49M shares representing 29.32% of the company. Kristina Burow's Neumora Therapeutics shares are currently valued at $31.34M.

If you're new to stock investing, here's how to buy Neumora Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.